Oral Glucocorticoids

DRUG4 trials

Sponsors

Beijing Tongren Hospital, Guangzhou JOYO Pharma Co., Ltd, Novartis Pharmaceuticals

Conditions

Chronic Rhinosinusitis With Nasal PolypsGlucocorticoidsNeuromyelitis Optica Spectrum DisordersVEXAS Syndrome

Phase 2

A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

RecruitingNCT06697535

Guangzhou JOYO Pharma Co., LtdNeuromyelitis Optica Spectrum Disorders

Start: 2023-05-24End: 2026-07-30Target: 35Updated: 2024-11-20

A 52-Week Study Evaluating the Efficacy and Safety of Arumakimig (MAS825) in Participants With VEXAS Followed by Open-Label Extension (OLE) Period

Not yet recruitingNCT07748624

Novartis PharmaceuticalsVEXAS Syndrome

Start: 2026-10-30End: 2031-04-21Target: 120Updated: 2026-08-06

Phase 4

CST1-Guided Oral Glucocorticoids Management for CRSwNP

Beijing Tongren HospitalChronic Rhinosinusitis With Nasal Polyps, Glucocorticoids

Start: 2022-10-17End: 2025-11-01Target: 90Updated: 2022-10-28

CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps

Beijing Tongren HospitalChronic Rhinosinusitis With Nasal Polyps, Glucocorticoids

Start: 2022-11-22End: 2025-11-01Target: 150Updated: 2023-03-10